Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Aurobindo Pharma will manufacture and supply long-acting injectable HIV treatment, cabotegravir, across 133 countries through ...

We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that ...

A new study explores how healthcare providers can effectively implement Apretude for HIV pre-exposure prophylaxis (PrEP) ...

The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government says it has saved the lives of over 25 million people around the world ...

As HIV cases continue to rise in the Philippines, especially among the youth, a new global development may offer hope in ...

A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...